matrigon 72 sg vandopløseligt granulat
dow agrosciences danmark a/s - clopyralid - vandopløseligt granulat - 720 g/kg clopyralid
primus 250 wg vanddispergerbart granulat
dow agrosciences danmark a/s - florasulam - vanddispergerbart granulat - 250 g/kg florasulam
starane 180s emulsionskoncentrat
dow agrosciences danmark a/s - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr
isomate clr feromon-dispenser
cbc (europe) s.r.l. - codlelure, (z)-11-tetradecen-1-yl, (z)-9-tetradecen-1-yl, dodecan-1-ol, tetradecan-1-ol - feromon-dispenser - 54,767 g/kg codlelure ; 52,326 g/kg (z)-11-tetradecen-1-yl acetate ; 10,465 g/kg (z)-9-tetradecen-1-yl acetate ; 8,488 g/kg dodecan-1-ol ; 1,802 g/kg tetradecan-1-ol
aq10 vanddispergerbart granulat
cbc (europe) s.r.l. - ampelomyces - vanddispergerbart granulat - 5000000000000 cfu/kg ampelomyces quisqualis m-10
gf-3307 emulsionskoncentrat
dow agrosciences danmark a/s - prothioconazol, fenpicoxamid - emulsionskoncentrat - 100 g/l prothioconazol; 50 g/l fenpicoxamid
matrigon 600 sl vandopløseligt koncentrat
dow agrosciences danmark a/s - clopyralid - vandopløseligt koncentrat - 600 g/l clopyralid
azuleo suspensionskoncentrat
isk biosciences products inc. - cyazofamid - suspensionskoncentrat - 160 g/l cyazofamid
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multipelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.